Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen

Vaccine

Volumn 24, Issue 37-39, 2006, Pages 6332-6339

  Michelon, André ^a   Conceição, Fabricio Rochedo ^a   Binsfeld, Pedro Canisio ^a   da Cunha, Cristina Wetzel ^a   Moreira, Ângela Nunes ^a   Argondizzo, Ana Paula ^a,b   McIntosh, Douglas ^b   Armôa, Geraldo R G ^b   Campos, Adriano S ^b   Farber, Marisa ^c   McFadden, Johnjoe ^d   Dellagostin, Odir Antônio ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Anaplasma marginale; Anaplasmosis; MSP1a; Recombinant BCG

Indexed keywords

ANAPLASMOSIS VACCINE; BACTERIAL ANTIGEN; BCG VACCINE; MAJOR SURFACE PROTEIN 1A; UNCLASSIFIED DRUG;

ANAPLASMA MARGINALE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; EXPRESSION VECTOR; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANAPLASMA MARGINALE; ANIMALS; ANTIBODY FORMATION; BACTERIAL OUTER MEMBRANE PROTEINS; BCG VACCINE; CATTLE; CLONING, MOLECULAR; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS;

EID: 33747356284     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.028     Document Type: Article

References (36)

1. Losos G.J. Anaplasmosis. In: Losos G.J. (Ed). Infectious tropical diseases of domestic animals (1986), Longman Scientific and Technical, New York 473-536
2. Kuttler K.L. Anaplasma infections in wild and domestic ruminants: a review. J Wildl Dis 20 1 (1984) 12-20
3. Kocan K.M., de la Fuente J., Guglielmone A.A., and Melendez R.D. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 16 4 (2003) 698-712
4. de la Fuente J., Garcia-Garcia J.C., Blouin E.F., and Kocan K.M. Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogen Anaplasma marginale to bovine erythrocytes and tick cells. J Int Parasitol 31 (2001) 145-153
5. de la Fuente J., Garcia-Garcia J.C., Blouin E.F., and Kocan K.M. Characterization of the functional domain of major surface protein 1a involved in adhesion of the rickettsia Anaplasma marginale to host cells. Vet Microbiol 91 2/3 (2003) 265-283
6. Palmer G.H., Waghela S.D., Barbet A.F., Davis W.C., and McGuire T.C. Characterization of a neutralization-sensitive epitope on the Am 105 surface protein of Anaplasma marginale. Int J Parasitol 17 7 (1987) 1279-1285
7. de la Fuente J., Kocan K.M., Garcia-Garcia J.C., et al. Antibodies to Anaplasma marginale major surface protein 1a reduce infectivity for ticks. J Appl Res Vet Med 1 (2003) 285-292
8. Bloom B.R., and Fine P.E.M. The BCG experience: implications for future vaccines against tuberculosis. In: Bloom B.R. (Ed). Tuberculosis: pathogenicity, protection, and control (1994), American Society for Microbiology, Washington, DC 531-557
9. Ohara N., and Yamada T. Recombinant BCG vaccines. Vaccine 19 30 (2001) 4089-4098
10. Stover C.K., Bansal G.P., Hanson M.S., Burlein J.E., Palaszynski S.R., Young J.F., et al. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med 178 1 (1993) 197-209
11. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Zuckermann F., et al. Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 22 3/4 (2004) 467-474
12. Varaldo P.B., Leite L.C., Dias W.O., Miyaji E.N., Torres F.I.G., Vera C.G., et al. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge. Infect Immun 72 6 (2004) 3336-3343
13. Govan VA, Christensen ND, Berkower C, Jacobs Jr WR, Williamson AL. Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge. Vaccine 2005 [Epub ahead of print].
14. Sambrook J., and Russell D.W. Molecular cloning: a laboratory manual (2001), Cold Spring Harbor Laboratory Press, New York
15. Le Dantec C., Winter N., Gicquel B., Vincent V., and Picardeau M. Genomic sequence and transcriptional analysis of a 23-kilobase mycobacterial linear plasmid: evidence for horizontal transfer and identification of plasmid maintenance systems. J Bacteriol 183 7 (2001) 2157-2164
16. Al-Zarouni M., and Dale J.W. Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains. Tuberculosis 82 6 (2002) 283-291
17. Dellagostin O.A., Esposito G., Eales L.J., Dale J.W., and McFadden J. Activity of mycobacterial promoters during intracellular and extracellular growth. Microbiology 141 Pt 8 (1995) 1785-1792
18. Ramos C.R., Abreu P.A., Nascimento A.L., and Ho P.L. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res 37 8 (2004) 1103-1109
19. Kocan K.M., Blouin E.F., and Barbet A.F. Anaplasmosis control. Past, present, and future. Ann NY Acad Sci 916 (2000) 501-509
20. Blouin E.F., Saliki J.T., de la Fuente J., Garcia-Garcia J.C., and Kocan K.M. Antibodies to Anaplasma marginale major surface proteins 1a and 1b inhibit infectivity for cultured tick cells. Vet Parasitol 111 (2003) 247-260
21. Brown W.C., McGuire T.C., Mwangi W., Kegerreis K.A., Macmillan H., Lewin H.A., et al. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a. Infect Immun 70 10 (2002) 5521-5532
22. Stover C.K., de lC V., Fuerst T.R., et al. New use of BCG for recombinant vaccines. Nature 351 6326 (1991) 456-460
23. Supply P., Sutton P., Coughlan S.N., Bilo K., Saman E., Trees A.J., et al. Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii. Vaccine 17 7/8 (1999) 705-714
24. Leung N.J., Aldovini A., Young R., Jarvis M.A., Smith J.M., Meyer D., et al. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Virology 268 1 (2000) 94-103
25. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., and Osorio F.A. Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine 21 1/2 (2002) 21-29
26. Medeiros M., Armôa G.R., Dellagostin O.A., and McIntosh D. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin. Can J Microbiol 51 (2005) 1015-1020
27. Nascimento I.P., Dias W.O., Mazzantini R.P., Miyaji E.N., Gamberini M., Quintilio W., et al. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect Immun 68 9 (2000) 4877-4883
28. Mazzantini R.P., Miyaji E.N., Dias W.O., Sakauchi D., Nascimento A.O., Raw I., et al. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C. Vaccine 22 5/6 (2004) 740-746
29. Horwitz M.A., Harth G., Dillon B.J., and Maslesa-Galic S. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity. Vaccine 24 4 (2006) 443-451
30. Brown W.C., Palmer G.H., Lewin H.A., and McGuire T.C. CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect Immun 69 11 (2001) 6853-6862
31. Brown W.C., McGuire T.C., Zhu D., Lewin H.A., Sosnow J., and Palmer G.H. Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses. J Immunol 166 2 (2001) 1114-1124
32. Garcia-Garcia J.C., de la Fuente J., Kocan K.M., Blouin E.F., Halbur T., Onet V.C., et al. Mapping of B-cell epitopes in the N-terminal repeated peptides of the Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens. Vet Immunol Immunopath 98 3/4 (2004) 137-151
33. Buddle B.M., Parlane N.A., Keen D.L., Aldwell F.E., Pollock J.M., Lightbody K., et al. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin Diagn Lab Immunol 6 1 (1999) 1-5
34. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., and Hewinson R.G. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 8 3 (2001) 571-578
35. Buddle B.M., McCarthy A.R., Ryan T.J., Pollock J.M., Vordermeier H.M., Hewinson R.G., et al. Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. Vet Rec 153 20 (2003) 615-620
36. Méderlé I., Bourguin I., Ensergueix D., Badell E., Moniz-Peireira J., Gicquel B., et al. Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses. Infect Immun 70 1 (2002) 303-314